Compare DOCN & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOCN | CRL |
|---|---|---|
| Founded | 2011 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 13.1B |
| IPO Year | 2021 | 1999 |
| Metric | DOCN | CRL |
|---|---|---|
| Price | $87.80 | $354.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 17 |
| Target Price | $173.80 | ★ $318.87 |
| AVG Volume (30 Days) | ★ 2.6M | 1.1M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.15 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | $901,427,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $30.79 | N/A |
| Revenue Next Year | $54.70 | $2.53 |
| P/E Ratio | $193.80 | ★ N/A |
| Revenue Growth | ★ 15.48 | 10.48 |
| 52 Week Low | $41.96 | $146.20 |
| 52 Week High | $187.50 | $379.63 |
| Indicator | DOCN | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 35.60 | 58.89 |
| Support Level | $73.66 | $151.03 |
| Resistance Level | $94.24 | N/A |
| Average True Range (ATR) | 7.71 | 16.11 |
| MACD | -1.24 | 0.88 |
| Stochastic Oscillator | 16.91 | 59.85 |
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.